Jan Berger, MD, MJ, begins the discussion by asking the panelists what they believe to be the biggest challenge in addressing diabetes.
Jan Berger, MD, MJ, begins the discussion by asking the panelists what they believe to be the biggest challenge in addressing diabetes.
Amy Tenderich, a patient with diabetes and an important advocate for patients with diabetes through her website Diabetes Mine, says, “I think there is sort of this breakdown in recognition of what the reality is of living with a chronic illness like diabetes. I think that if this were permeated throughout the pharma industry, throughout payers, providers—a better understanding of what that is actually like—we would have better solutions today.”
Maria Lopes, MD, MS, explains that there is no blanket solution to fix the problem at large. She says, “What makes patients change, and what do they need to change? It is not a phone call. It is certainly not a newsletter, and when you hang up the phone with that patient, maybe 5 other phone calls have to take place to actually fix the problem that starts with understanding at the patient level what is driving nonadherence.”
Josh Benner, PhD, ScD, adds, “How do we improve the health of the population while being patient-centered or personalized in our approach? Because the past 2 decades of old-style disease management have proven to us that you just can't blast a population with a 1-size-fits-all intervention and expect your problems to go away, your health status to improve.”
According to Ms Tenderich, perhaps a motivational tool is something that should be considered. She says, “The challenge, the core challenge with an illness like diabetes, is remember this is for life, this is not going away, and when I look ahead, I mean I have had diabetes for 10 years now, and I mean I don't hardly know anyone with type 1 who is an adult who hasn't experienced clinical depression.”
She adds, “People feel that they are being punished with this illness, and we talk about programs that incentivize providers, and that is great, but there needs to be some reward or some sense of accomplishment that the patient can have over time.”
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
What We’re Reading: ACA Perception; FDA Blood Sugar Warning; AI and Physician Burnout
February 22nd 2024More than half of US adults have a favorable view of the Affordable Care Act (ACA); smartwatches and rings that claim to measure blood sugar levels without piercing the skin could be dangerous and should be avoided; many believe artificial intelligence (AI) could be the solution to physician burnout.
Read More
Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations
February 15th 2024Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.
Read More